CB
Camille Bedrosian
Assistant Consulting Professor in the Department of Medicine · Duke University Hospital
Credentials: · · ·
History
Present
- 1983–1984
- 1979–1983
Research
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
New England Journal of Medicine · 2013 · 1,219 citations
C3 glomerulopathy: consensus report
Kidney International · 2013 · 484 citations
Kidney International · 2015 · 315 citations
4 papers
- AT
2 papers
2 papers
2 papers
- DM
2 papers
2 papers
- MM
2 papers · 1 as a fellow
2 papers
Clinical trials
- 2023–2028
AMX0035 in Adult Patients With Wolfram Syndrome
Study director · Active not recruiting · Phase 2
Amylyx Pharmaceuticals Inc.